---
title: "US FDA grants breakthrough designation for Pi-Cardia’s ShortCut leaflet splitting device"
date: "2024-01-22T17:18:11.000Z"
publishedDate: "22 janvier 2024"
summary: "Pi-Cardia has received breakthrough device designation from the US Food and Drug Administration (FDA) for the ShortCut leaflet modification device facilitating valve-in-valve transcatheter aortic valve implantation (TAVI) procedures in patients at risk of coronary obstruction. The announcement comes after completion of enrolment in the ShortCut Pivotal study in the USA and Europe in September 2023."
importance: ""
sourceUrl: "https://cardiovascularnews.com/breakthrough-designation-shortcut/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-01-22-us-fda-grants-breakthrough-designation-for-pi-cardias-shortcut-leaflet-splitting-device"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/12/pi-cardia-logo-01.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/breakthrough-designation-shortcut/"
---

![US FDA grants breakthrough designation for Pi-Cardia’s ShortCut leaflet splitting device](https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/12/pi-cardia-logo-01.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/breakthrough-designation-shortcut/*

## L’essentiel

Pi-Cardia has received breakthrough device designation from the US Food and Drug Administration (FDA) for the ShortCut leaflet modification device facilitating valve-in-valve transcatheter aortic valve implantation (TAVI) procedures in patients at risk of coronary obstruction. The announcement comes after completion of enrolment in the ShortCut Pivotal study in the USA and Europe in September 2023.

## Lien source

https://cardiovascularnews.com/breakthrough-designation-shortcut/
